Madrigal Pharmaceuticals EBIT 2010-2024 | MDGL
- Madrigal Pharmaceuticals 2023 EBIT was -0.38B, a 29.61% increase from 2022.
- Madrigal Pharmaceuticals 2022 EBIT was -0.294B, a 21.07% increase from 2021.
- Madrigal Pharmaceuticals 2021 EBIT was -0.242B, a 17.33% increase from 2020.
EBIT can be defined as earnings before interest and taxes.